Company · CIK 0000879407 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
ARROWHEAD PHARMACEUTICALS, INC. · ARWR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2015 AForm 4 → | Mar 6, 8:12 pm EST | Christopher Richard AnzalonePresident and CEO, Director | 360,000 | — | — | 620,173 | — | plan? |
| Mar 4, 2015 AForm 4 → | Mar 6, 8:07 pm EST | Kenneth Allen MyszkowskiCFO | 50,000 | — | — | 121,500 | — | plan? |
| Mar 4, 2015 AForm 4 → | Mar 6, 7:48 pm EST | Charles McKenneyDirector | 25,000 | — | — | 42,220 | — | plan? |
| Mar 4, 2015 AForm 4 → | Mar 6, 7:45 pm EST | Edward W FrykmanDirector | 25,000 | — | — | 48,852 | — | plan? |
| Mar 4, 2015 AForm 4 → | Mar 6, 7:43 pm EST | Michael S PerryDirector | 30,000 | — | — | 45,000 | — | plan? |
| Mar 4, 2015 AForm 4 → | Mar 6, 7:40 pm EST | Douglas B GivenDirector | 35,000 | — | — | 55,000 | — | plan? |
| Jan 5, 2015 SForm 4 → | Jan 7, 5:50 pm EST | David L. LewisChief Scientific Officer | 15,000 | $8.01 | $120,104 | 0 | −100% | plan? |
| Jan 5, 2015 MForm 4 → | Jan 7, 5:50 pm EST | David L. LewisChief Scientific Officer | 15,000 | $2.01 | $30,150 | 15,000 | — | plan? |
| Oct 9, 2013 PForm 4 → | Jan 14, 2015, 6:10 pm EST | Mauro FerrariDirector | 2,300 | $6.44 | $14,808 | 4,251 | +118% | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2019 MForm 4 → | Mar 1, 8:42 pm EST | Bruce D GivenChief Operating Officer | 42,500 | — | — | 350,000 | — | |
| Feb 26, 2019 MForm 4 → | Feb 26, 7:32 pm EST | Douglas B GivenDirector | 65,000 | — | — | 0 | — | |
| Feb 25, 2019 MForm 4 → | Feb 27, 7:08 pm EST | Bruce D GivenChief Operating Officer | 42,500 | — | — | 392,500 | — | |
| Feb 19, 2019 MForm 4 → | Feb 20, 8:12 pm EST | Kenneth Allen MyszkowskiChief Financial Officer | 8,000 | — | — | 235,000 | — | |
| Feb 19, 2019 MForm 4 → | Feb 20, 8:09 pm EST | Bruce D GivenChief Operating Officer | 42,500 | — | — | 435,000 | — | |
| Feb 8, 2019 MForm 4 → | Feb 12, 8:58 pm EST | Bruce D GivenChief Operating Officer | 65,834 | — | — | 477,500 | — | |
| Jan 14, 2019 MForm 4 → | Jan 16, 8:18 pm EST | Bruce D GivenChief Operating Officer | 12,666 | — | — | 543,334 | — | |
| Oct 19, 2018 MForm 4 → | Oct 23, 7:59 pm EDT | Peter Brian LeoneVP, Strategic Bus. Initiatives | 131,137 | — | — | 88,863 | — | |
| Sep 6, 2018 MForm 4 → | Sep 10, 6:32 pm EDT | Kenneth Allen MyszkowskiChief Financial Officer | 45,000 | — | — | 243,000 | — | |
| Jun 19, 2018 MForm 4 → | Jun 20, 9:18 pm EDT | Kenneth Allen MyszkowskiChief Financial Officer | 20,000 | — | — | 288,000 | — | |
| May 30, 2018 MForm 4 → | Jun 1, 5:34 pm EDT | Kenneth Allen MyszkowskiChief Financial Officer | 14,000 | — | — | 308,000 | — | |
| Mar 27, 2018 MForm 4 → | Mar 27, 7:46 pm EDT | Kenneth Allen MyszkowskiChief Financial Officer | 20,000 | — | — | 322,000 | — | |
| Aug 22, 2016 MForm 4/A → | Aug 26, 5:52 pm EDT | Kenneth Allen MyszkowskiChief Financial Officer | 20,000 | — | — | 342,000 | — | |
| Aug 22, 2016 MForm 4 → | Aug 24, 6:39 pm EDT | Kenneth Allen MyszkowskiChief Financial Officer | 20,000 | — | — | 342,000 | — | amended |
| Jun 30, 2016 XForm 4 → | Jul 5, 6:11 pm EDT | Christopher Richard AnzaloneChief Executive Officer, Director | 15,772 | — | — | 0 | — | |
| Jan 1, 2016 AForm 4 → | Jan 4, 7:31 pm EST | Peter Brian LeoneVP, Strategy & Program Mgmt | 50,000 | — | — | 220,000 | — | |
| Jan 1, 2016 AForm 4 → | Jan 4, 7:30 pm EST | Patrick O'BrienGeneral Counsel | 60,000 | — | — | 150,000 | — | |
| Jan 1, 2016 AForm 4 → | Jan 4, 7:24 pm EST | David L. LewisChief Scientific Officer | 85,000 | — | — | 472,500 | — | |
| Jan 1, 2016 AForm 4 → | Jan 4, 7:22 pm EST | Bruce D GivenChief Operating Officer | 60,000 | — | — | 556,000 | — | |
| Jan 1, 2016 AForm 4 → | Jan 4, 7:19 pm EST | Kenneth Allen MyszkowskiChief Financial Officer | 40,000 | — | — | 362,000 | — | |
| Jan 1, 2016 AForm 4 → | Jan 4, 7:15 pm EST | Christopher Richard AnzaloneChief Executive Officer, Director | 80,000 | — | — | 1,166,466 | — | |
| Mar 6, 2015 AForm 4 → | Mar 10, 5:09 pm EDT | David L. LewisChief Scientific Officer | 100,000 | — | — | 387,500 | — | |
| Mar 6, 2015 AForm 4 → | Mar 6, 8:17 pm EST | Bruce D GivenChief Operating Officer | 60,000 | — | — | 496,000 | — | |
| Mar 6, 2015 AForm 4 → | Mar 6, 8:12 pm EST | Christopher Richard AnzalonePresident and CEO, Director | 300,000 | — | — | 1,086,466 | — | |
| Mar 6, 2015 AForm 4 → | Mar 6, 8:07 pm EST | Kenneth Allen MyszkowskiCFO | 50,000 | — | — | 322,000 | — | |
| Jan 5, 2015 MForm 4 → | Jan 7, 5:50 pm EST | David L. LewisChief Scientific Officer | 15,000 | — | — | 287,500 | — |